Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study

Objective The effects of dehydroepiandrosterone (DHEA) supplementation in Saudi Arabian women with poor ovarian response (POR) is presently unknown. The present study aimed to assess the benefits of DHEA supplementation in women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injec...

Full description

Bibliographic Details
Main Author: Haifa A. Al-Turki
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060517720005
_version_ 1818937622396928000
author Haifa A. Al-Turki
author_facet Haifa A. Al-Turki
author_sort Haifa A. Al-Turki
collection DOAJ
description Objective The effects of dehydroepiandrosterone (DHEA) supplementation in Saudi Arabian women with poor ovarian response (POR) is presently unknown. The present study aimed to assess the benefits of DHEA supplementation in women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Methods This was a prospective case-control study involving 62 women who were diagnosed with POR and underwent IVF/ICSI between January 2012 and June 2016. The positive influence of DHEA in 34 women, compared with 28 women without supplementation, was defined as improvements in the number of oocytes retrieved, the fertilization rate, the number of grade I embryos generated and the pregnancy rate. Results Both groups were evenly matched for age, body mass index and laboratory test parameters. There were statistically significant differences between the groups with and without DHEA supplementation for oocyte yield (6.35 ± 2.41 versus 3.98 ± 3.2), Grade I embryos generated (55% versus 30%), positive pregnancy rate (21/34 versus 10/28), and live birth rate (18/34 versus 4/28). Conclusion DHEA supplementation in women with POR had a positive effect on hormonal profiles, the quality of the endometrium, the number of oocytes retrieved, the quality of embryos, and the pregnancy and live birth rates.
first_indexed 2024-12-20T05:54:53Z
format Article
id doaj.art-aa0c62f9b2bc499eb0c66199ff155d36
institution Directory Open Access Journal
issn 0300-0605
1473-2300
language English
last_indexed 2024-12-20T05:54:53Z
publishDate 2018-01-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-aa0c62f9b2bc499eb0c66199ff155d362022-12-21T19:51:04ZengSAGE PublishingJournal of International Medical Research0300-06051473-23002018-01-014610.1177/0300060517720005Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control studyHaifa A. Al-TurkiObjective The effects of dehydroepiandrosterone (DHEA) supplementation in Saudi Arabian women with poor ovarian response (POR) is presently unknown. The present study aimed to assess the benefits of DHEA supplementation in women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Methods This was a prospective case-control study involving 62 women who were diagnosed with POR and underwent IVF/ICSI between January 2012 and June 2016. The positive influence of DHEA in 34 women, compared with 28 women without supplementation, was defined as improvements in the number of oocytes retrieved, the fertilization rate, the number of grade I embryos generated and the pregnancy rate. Results Both groups were evenly matched for age, body mass index and laboratory test parameters. There were statistically significant differences between the groups with and without DHEA supplementation for oocyte yield (6.35 ± 2.41 versus 3.98 ± 3.2), Grade I embryos generated (55% versus 30%), positive pregnancy rate (21/34 versus 10/28), and live birth rate (18/34 versus 4/28). Conclusion DHEA supplementation in women with POR had a positive effect on hormonal profiles, the quality of the endometrium, the number of oocytes retrieved, the quality of embryos, and the pregnancy and live birth rates.https://doi.org/10.1177/0300060517720005
spellingShingle Haifa A. Al-Turki
Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
Journal of International Medical Research
title Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
title_full Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
title_fullStr Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
title_full_unstemmed Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
title_short Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
title_sort dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response a prospective case control study
url https://doi.org/10.1177/0300060517720005
work_keys_str_mv AT haifaaalturki dehydroepiandrosteronesupplementationinwomenundergoingassistedreproductivetechnologywithpoorovarianresponseaprospectivecasecontrolstudy